Market view
caffeine · Powder
0 marketed package NDCs · 4 makers active in the last 30 days
Not counted: 18 bulk-ingredient, export-only or further-processing listings.
ⓘ How this was built
- FDA NDC Directory (openFDA), read daily — package listings, marketing category, labeler
- DailyMed SPL establishment roles + name patterns → derived.labeler_kinds (repackager classification)
Marketed package NDCs are listings for this exact FDA generic-name string (and dosage form, when one is selected) that are in the current directory file and are finished products — bulk ingredients, export-only and further-processing listings are excluded and counted separately. Makers are distinct labeler names seen in the last 30 days minus classified repackagers/relabelers; a listing is not proof of shipping volume. To check: search the generic name in FDA's NDC Directory and count labelers.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
Same molecule, listed under other names (separate rosters and prices): caffeine tablet, film-coated (4 NDCs)
What changed in the last 90 days
Every detected change for caffeine, newest first — price moves, shortages, recalls, and labelers entering or leaving. Detected by comparing each day’s federal data against what we already held.
ⓘ How this was built
- DrugDashboards change feed — daily diffs of the NDC Directory, NADAC, FDA shortages and enforcement reports, Part D formularies
Events whose NDC belongs to a product with this generic-name string, dated by the day the change was detected (the file's own effective date is shown on price rows). Generic NADAC is a 3-month moving average since December 2024, so most price moves here are small and lag the market.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
- Stay AwakeAug 19, 2026Price downNADAC $0.0849 → $0.0848 per EA (-0.11%) · effective Aug 19, 2026
- Stay AwakeAug 19, 2026Price downNADAC $0.0849 → $0.0848 per EA (-0.11%) · effective Aug 19, 2026
- CaffeineAug 19, 2026Price downNADAC $0.0849 → $0.0848 per EA (-0.11%) · effective Aug 19, 2026
- Alert AidAug 19, 2026Price downNADAC $0.0849 → $0.0848 per EA (-0.11%) · effective Aug 19, 2026
- Alertness AidAug 12, 2026Labeler exitedChain Drug Consortium · caffeine
- Stay AwakeJul 22, 2026Price upNADAC $0.0847 → $0.0849 per EA (+0.26%) · effective Jul 22, 2026
- CaffeineJul 22, 2026Price upNADAC $0.0847 → $0.0849 per EA (+0.26%) · effective Jul 22, 2026
- Alert AidJul 22, 2026Price upNADAC $0.0847 → $0.0849 per EA (+0.26%) · effective Jul 22, 2026
- Stay AwakeJul 22, 2026Price upNADAC $0.0847 → $0.0849 per EA (+0.26%) · effective Jul 22, 2026
Same drug class
Other molecules FDA puts in Methylxanthine, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
ⓘ How this was built
- FDA NDC Directory pharmacologic class (EPC) per product
- FDA drug shortages (openFDA)
- FDA NDC Directory labelers + derived.labeler_kinds
Peers share this drug's most common Established Pharmacologic Class. 'In shortage' means an FDA Current row whose NDC belongs to that molecule or whose listing name normalizes to it (any presentation). Maker counts are labelers active in the last 30 days minus repackagers, across all forms.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
- acetaminophen, caffeine, dihydrocodeine bitartrate
- butal/apap/caff
- butal/apap/caffeine
- butalbital/acetaminophen/caffeine
- 5% minoxidil hair growth foam· 1 maker
- acetaldehyde, aceticum ac, arg nit, caffeinum, calc sulph, citricum ac, cortisone aceticum, echinacea purp, folliculinum, fragaria, fumaricum ac, gallicum ac, glandula suprarenalis suis, hepar suis, histaminum hydrochloricum, hydrangea, lac vac, lecithin, limulus, lycopersicum, lycopodium, nat bicarb, nat mur, nux vom, paraffinum, phosphoricum ac, saccharum off, silicea, tartaricum ac, torula cerevisiae.· 1 maker
- acetaminophen , aspirin and caffeine· 1 maker
- acetaminophen , caffeine and pyrilamine maleate· 1 maker
- acetaminophen 250 mg aspirin 250 mg caffeine 65 mg· 1 maker
- acetaminophen 250 mg, aspirin 250 mg, and caffeine 65 mg· 1 maker
- acetaminophen 250mg, aspirin 250mg and caffeine 65mg· 1 maker
- acetaminophen 500 mg with caffeine 65mg· 1 maker
Common questions
- Is Caffeine in shortage right now?
- No. FDA's shortage list has no current entry for Caffeine under this name or its presentations. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Caffeine?
- 45 companies have listed Caffeine in the FDA NDC Directory in the last 30 days. A listing is not proof of volume; the products below show every listed package.
- What does Caffeine cost?
- The typical pharmacy pays about $0.0848 per unit for Caffeine — the median of 4 package NDCs' latest CMS NADAC prices (last 6 months, unit-priced products only). That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.
ⓘ How this was built
- FDA drug shortages (openFDA)
- FDA NDC Directory + derived.labeler_kinds
- CMS NADAC weekly file
Shortage: any Current FDA row whose package NDC belongs to this generic-name string or whose listing name normalizes to the same molecule; the presentations named are those rows. Makers: distinct labelers listing this string in the last 30 days, repackagers excluded. Cost: the median of each NDC's most recent NADAC within 6 months, restricted to the market's most common billing unit and to the generic cohort when one exists.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
All marketed products
0 marketed NDCs, every one listed. NADAC prices show the file date; prices older than 6 months are greyed.
ⓘ How this was built
- FDA NDC Directory (openFDA) — products, packages, labelers, marketing category, TE code (application-level)
- CMS NADAC — each NDC's latest price
- DrugDashboards fragility v1 score
Finished products currently in the NDC Directory under this generic-name string (bulk, export-only and further-processing listings excluded). 'Widely marketed' marks the four form/strength/package combinations with the most NADAC-priced NDCs — a proxy for retail availability, not dispensing volume. Labeler counts in the tree include repackagers, marked in the roster on each drug page.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
No finished products are currently listed under this name.